Premium
Prevalence and clinical features of cough variant asthma in a general internal medicine outpatient clinic in Japan
Author(s) -
SHIRAHATA Kumiko,
FUJIMOTO Keisaku,
ARIOKA Hiroko,
SHOUDA Ryousuke,
KUDO Kouichirou,
IKEDA Shuichi
Publication year - 2005
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2005.00709.x
Subject(s) - medicine , evening , morning , asthma , chronic cough , outpatient clinic , bronchodilator , bronchial hyperresponsiveness , spirometry , fluticasone propionate , prospective cohort study , pediatrics , respiratory disease , lung , physics , astronomy
Objective: The aims of the present study were to examine the prevalence and clinical features of cough variant asthma (CVA) among patients with chronic and persistent cough at an outpatient clinic in Japan, and the efficacy of treatment with an inhaled corticosteroid. Methodology: This prospective study was conducted at a general internal medicine outpatient clinic in Japan over a 12‐month period. CVA was diagnosed as chronic cough without wheezing or any apparent cause, that had persisted for more than 8 weeks, with a normal CXR and spirometry but with bronchial hyperresponsiveness to methacholine, and relief of cough after bronchodilator treatment. We also examined the effects of inhaled beclomethasone propionate on symptoms and differences in PEF between early morning and evening. Results: Of 55 patients suffering from chronic cough, 23 satisfied the criteria for CVA. Their cough occurred more frequently at night and early in the morning. Early morning PEF was significantly lower than evening PEF with a mean variability of 11.5 ± 4.1%. Treatment with beclomethasone propionate improved coughing and significantly increased early morning PEF, reducing variability to less than 10%. Conclusions: These findings suggest that CVA is most common among patients with chronic cough not due to any apparent cause. The efficacy of inhaled corticosteroid suggests that early intervention is effective in the treatment of CVA.